Conference Reports for NATAP
ID Week 2025
October 19-22
Atlanta, GA
Back
 
Tweet
Safety and Effectiveness of Long-Acting Cabotegravir/Rilpivirine
in People with HIV and Severe Renal Impairment (CAPRI)
 
IDWeek 2025 Oct 19-22 Atlanta